| Primary |
| Fibromyalgia |
17.4% |
| Pain |
14.2% |
| Neuralgia |
13.9% |
| Neuropathy Peripheral |
7.9% |
| Hypertension |
7.3% |
| Diabetic Neuropathy |
4.5% |
| Back Pain |
3.9% |
| Depression |
3.8% |
| Diabetes Mellitus |
3.6% |
| Ill-defined Disorder |
3.5% |
| Post Herpetic Neuralgia |
3.0% |
| Pain In Extremity |
2.9% |
| Anxiety |
2.9% |
| Herpes Zoster |
1.9% |
| Nerve Injury |
1.8% |
| Blood Cholesterol Increased |
1.7% |
| Sleep Disorder |
1.6% |
| Arthritis |
1.4% |
| Insomnia |
1.3% |
| Sciatica |
1.3% |
|
| Weight Increased |
19.7% |
| Pain |
11.6% |
| Somnolence |
9.1% |
| Vision Blurred |
8.5% |
| Drug Ineffective |
7.7% |
| Oedema Peripheral |
5.0% |
| Withdrawal Syndrome |
4.5% |
| Tremor |
3.8% |
| Pain In Extremity |
3.6% |
| Dizziness |
3.2% |
| Malaise |
2.9% |
| Vomiting |
2.7% |
| Death |
2.6% |
| Rash |
2.5% |
| Feeling Abnormal |
2.4% |
| Weight Decreased |
2.3% |
| Nausea |
2.3% |
| Visual Impairment |
2.1% |
| Suicidal Ideation |
2.0% |
| Convulsion |
1.5% |
|
| Secondary |
| Pain |
15.6% |
| Fibromyalgia |
13.1% |
| Neuralgia |
9.4% |
| Product Used For Unknown Indication |
8.0% |
| Neuropathy Peripheral |
7.8% |
| Hypertension |
7.2% |
| Depression |
4.7% |
| Back Pain |
4.6% |
| Pain In Extremity |
3.8% |
| Anxiety |
3.6% |
| Diabetes Mellitus |
3.0% |
| Drug Use For Unknown Indication |
2.7% |
| Diabetic Neuropathy |
2.6% |
| Nerve Injury |
2.5% |
| Sleep Disorder |
2.2% |
| Blood Cholesterol Increased |
2.0% |
| Arthritis |
2.0% |
| Hypoaesthesia |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Post Herpetic Neuralgia |
1.6% |
|
| Weight Increased |
21.5% |
| Pain |
11.4% |
| Somnolence |
8.7% |
| Vision Blurred |
7.4% |
| Drug Ineffective |
7.0% |
| Withdrawal Syndrome |
5.8% |
| Pain In Extremity |
4.0% |
| Tremor |
4.0% |
| Weight Decreased |
4.0% |
| Vomiting |
3.7% |
| Off Label Use |
3.4% |
| Oedema Peripheral |
2.8% |
| Visual Impairment |
2.6% |
| Dizziness |
2.4% |
| Visual Acuity Reduced |
2.1% |
| Paraesthesia |
2.1% |
| Malaise |
2.0% |
| Nausea |
1.9% |
| Suicidal Ideation |
1.7% |
| Therapeutic Response Unexpected |
1.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.4% |
| Pain |
11.7% |
| Drug Use For Unknown Indication |
11.4% |
| Hypertension |
5.4% |
| Depression |
4.7% |
| Rheumatoid Arthritis |
4.4% |
| Multiple Sclerosis |
4.0% |
| Fibromyalgia |
3.4% |
| Diabetes Mellitus |
3.0% |
| Multiple Myeloma |
2.5% |
| Prophylaxis |
2.5% |
| Osteoporosis |
2.3% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Anxiety |
2.2% |
| Back Pain |
2.1% |
| Neuralgia |
2.0% |
| Neuropathy Peripheral |
1.9% |
| Insomnia |
1.9% |
| Asthma |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
|
| Vomiting |
13.1% |
| Weight Decreased |
8.8% |
| Weight Increased |
7.1% |
| Pain |
6.9% |
| Wrong Technique In Drug Usage Process |
5.6% |
| Pneumonia |
5.5% |
| Death |
5.2% |
| Drug Ineffective |
5.0% |
| Urinary Tract Infection |
4.9% |
| Nausea |
4.6% |
| Somnolence |
4.2% |
| Pyrexia |
3.8% |
| Pulmonary Embolism |
3.6% |
| Pain In Extremity |
3.6% |
| Tremor |
3.6% |
| Thrombocytopenia |
3.2% |
| Vision Blurred |
3.1% |
| Dyspnoea |
3.0% |
| Rash |
2.7% |
| Oedema Peripheral |
2.6% |
|
| Interacting |
| Pain |
18.6% |
| Neuralgia |
11.9% |
| Fibromyalgia |
9.7% |
| Depression |
7.6% |
| Drug Use For Unknown Indication |
7.0% |
| Neuropathy Peripheral |
4.8% |
| Hypertension |
4.3% |
| Back Pain |
4.0% |
| Herpes Zoster |
3.7% |
| Anxiety |
3.2% |
| Sleep Disorder |
3.2% |
| Convulsion |
3.0% |
| Product Used For Unknown Indication |
3.0% |
| Spinal Column Stenosis |
2.6% |
| Osteoporosis |
2.4% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Pain In Extremity |
2.3% |
| Bone Pain |
2.1% |
| Bipolar Disorder |
2.0% |
| Blood Cholesterol Increased |
2.0% |
|
| Somnolence |
15.8% |
| Drug Interaction |
14.0% |
| Weight Increased |
8.9% |
| Headache |
7.4% |
| Tremor |
5.7% |
| Vision Blurred |
5.7% |
| Pain |
4.9% |
| Hallucination |
4.3% |
| Weight Decreased |
3.7% |
| Vomiting |
3.4% |
| Respiratory Tract Congestion |
3.2% |
| Oedema Peripheral |
2.9% |
| Urticaria |
2.9% |
| Flatulence |
2.6% |
| Suicidal Ideation |
2.6% |
| Visual Impairment |
2.6% |
| Withdrawal Syndrome |
2.6% |
| Hypersomnia |
2.3% |
| Hypertension |
2.3% |
| Off Label Use |
2.3% |
|
